Yüklüyor......
RAS-MAPK in ALK targeted therapy resistance
The clinical success of ALK targeted therapy is limited by resistance. To identify rational co-targeting strategies to enhance clinical outcomes, we explored the molecular basis of ALK oncogene dependence in ALK gene rearrangement positive (ALK+) lung adenocarcinoma. We discovered that the RAS-RAF-M...
Kaydedildi:
| Yayımlandı: | Cell Cycle |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825705/ https://ncbi.nlm.nih.gov/pubmed/26654768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1096103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|